Telix Pharmaceuticals (ASX:TLX has announced a collaboration with Winship Cancer Institute of Emory University for the purpose of prostate cancer imaging. As quoted in the press release: The trial is led by Winship radiation oncologist Ashesh Jani, MD, and Emory radiologist and nuclear medicine physician David Schuster, MD. The collaboration, funded by a USD $3.4m … Continued
The post Telix Pharmaceuticals and Emory Winship Cancer Institute to Collaborate on Clinical Trial appeared first on Investing News Network.